﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Academy of Medical Sciences of I.R. Iran</PublisherName>
      <JournalTitle>Archives of Iranian Medicine</JournalTitle>
      <Issn>1029-2977</Issn>
      <Volume>21</Volume>
      <Issue>5</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2018</Year>
        <Month>05</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The Prevalence of PCR-Confirmed Pertussis Cases in Palestine From Archived Nasopharyngeal Samples</ArticleTitle>
    <FirstPage>208</FirstPage>
    <LastPage>212</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Kamal</FirstName>
        <LastName>Dumaidi</LastName>
      </Author>
      <Author>
        <FirstName>Amer</FirstName>
        <LastName>Al-Jawabreh</LastName>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">
      </ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2017</Year>
        <Month>12</Month>
        <Day>10</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2018</Year>
        <Month>04</Month>
        <Day>08</Day>
      </PubDate>
    </History>
    <Abstract>Background: Pertussis caused by Bordetella pertussis is a vaccine-preventable disease causing whooping cough in humans of all ages. This study reports infection rate of pertussis in Palestine between the years 2004-2008 from archived nasopharyngeal samples collected from clinically- suspected cases. Methods: A convenience archived DNA samples collected from 267 clinically-suspected pertussis cases were investigated for B. pertussis. Laboratory diagnosis was done by examining all DNA samples using polymerase chain reaction (PCR). Results: Approximately 49% (130/267) were confirmed by PCR. A pertussis peak was shown to occur in 2008 with 77% (100/130) of PCR-confirmed cases isolated in that year. PCR-confirmed cases existed in all Palestinian districts with highest rate in Ramallah, Bethlehem, Jenin and Al-Khalil. Half of the PCR-confirmed cases (68/130) were less than 2 months old. The positivity rate among who had three doses of vaccine (at 2, 4 and 6 months) was 38%, and became 50% with the fourth dose at 12 months. Conclusion: The prevalence of pertussis was found to be significantly high among infants less than 2 months old. Active pertussis surveillance using rapid PCR assays is essential, as it is helpful in prompt diagnosis and treatment of patients with pertussis. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Acellular pertussis vaccine (aP)</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Bordetella pertussis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Palestine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">PCR</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Pertussis vaccine</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Whole-cell pertussis vaccine (wP)</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>